Drug
Met233
Met233: highest development phase Phase 1, developed by Pfizer. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Pfizer
Trials
| Drug | Phase | Indication |
|---|---|---|
| MET233 NCT07022977 | Phase 1 | Obesity and Overweight |
Latest
No recent events.
Follow Met233 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.